Tamoxifen Citrate Tablets IP In Stock
Liver Disease

Tamoxifen Citrate Tablets IP

Tamoxifen Citrate Tablets IP is an anti-estrogen medicine used in the treatment of hormone receptor-positive breast cancer and to help reduce the risk of breast cancer recurrence in appropriate patients.

Product Details

Tamoxifen Citrate Tablets IP contains tamoxifen, a selective estrogen receptor modulator (SERM) used in the management of certain hormone receptor-positive breast cancers. It works by blocking the effects of estrogen in breast tissue, helping slow or prevent the growth of estrogen-dependent cancer cells.

Key Benefits
- Used in the treatment of hormone receptor-positive breast cancer
- Helps reduce the risk of breast cancer recurrence in appropriate patients
- May be used in certain patients to reduce the risk of developing breast cancer
- Blocks estrogen activity in breast tissue
- Supports long-term hormonal therapy as prescribed by an oncologist
How It Works
Tamoxifen binds to estrogen receptors in breast tissue and blocks the action of estrogen. Since some breast cancer cells depend on estrogen signals to grow, reducing estrogen activity at these receptors can help slow or prevent the growth of hormone-sensitive cancer cells.
Common Side Effects
- Hot flashes
- Night sweats
- Nausea
- Fatigue
- Headache
- Mood changes
- Vaginal discharge or dryness
- Menstrual changes
Important Information
Tamoxifen Citrate Tablets IP should be used only under the supervision of a qualified oncologist or healthcare professional. Treatment may require regular medical follow-up to monitor response and potential adverse effects. Tamoxifen can increase the risk of blood clots and, in some patients, certain uterine abnormalities or cancers. Inform your doctor about any history of blood clots, stroke, uterine problems, or other medical conditions, as well as all medicines you are taking. Seek immediate medical attention for sudden chest pain, breathing difficulty, coughing blood, unusual vaginal bleeding, or swelling and pain in a leg.